Identification of novel inhibitor against dengue NS5

Kavita Niranjan, Manoj Kumar, Suhasini Bhatnagar


Dengue fever, a neglected emerging disease for which no vaccine or antiviral agents exist at present, is caused by dengue virus, a member of the Flavivirus genus, which includes several important human pathogens, such as yellow fever and West Nile viruses. The NS5 protein from dengue virus is bifunctional and contains 900 amino acids. The S-adenosyl methionine transferase activity resides within its N-terminal domain, and residues 270 to 900 form the RNA-dependent RNA polymerase (RdRp) catalytic domain. Viral replication begins with the synthesis of minus-strand RNA from the dengue virus positive-strand RNA genome, which is subsequently used as a template for synthesizing additional plus-strand RNA genomes. This essential function for the production of new viral particles is catalyzed by the NS5 RdRp.

In this scenario, the present study aims to identify new molecules which could block or suppress the activity of RNA dependent RNA polymerase enzyme by molecular docking studies using Autodock Vina. In this study we used in silico approach by modeling NS5 protein, Optimization of the structure was done by adding polar hydrogens and Kollman charges using Pyrx .We further carried out docking studies by means of Autodock Vina, with various phytochemicals. Based on binding energy, phytochemicals were screeened and their interaction with NS5 was identified. Thus, we report Rohitukine alkaloid that has successfully satisfied all in silico parameters, necessitating further in vitro and in vivo studies.

The improved conditions and new structural information should accelerate structure-based design of antiviral compounds against Dengue virus. 


flavivirus; dengue virus; NS5 polymerase, Molecular Docking, AutoDock/Vina, Medicinal Plants, Alkaloid

Full Text:



Gubler DJ: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11(3):480-496.]

World Health Organization. Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control. 2nd edition. ed. Geneva; 1997.

World Health Organization. Dengue,guidelines for diagnosis, treatment and control. World Health Organization. Geneva; 2009.

Brady OJ, Gething PW, Bhatt S, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760.

Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. Lancet Infect Dis. 2016;16(8):935–941.

HALSTEAD, S. B. 2008. Dengue, Imperial College Press.

WHITEHEAD, S. S., BLANEY, J. E., DURBIN, A. P. & MURPHY, B. R. 2007. Prospects for a dengue virus vaccine. Nat Rev Microbiol, 5, 518-28.

Lim, S.P.; Noble, C.G.; Shi, P.-Y. The dengue virus NS5 protein as a target for drug discovery. Antiviral Res. 2015, 119, 57–67. [CrossRef] [PubMed]

Upadhyay, A.K.; Cyr, M.; Longenecker, K.; Tripathi, R.; Sun, C.; Kempf, D.J. Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5. Acta Crystallogr. Sect. F Struct. Biol. Commun. 2017, 73, 116–122.

Godoy, A.S.; Lima, G.M.A.; Oliveira, K.I.Z.; Torres, N.U.; Maluf, F.V.; Guido, R.V.C.; Oliva, G. Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase. Nat. Commun. 2017, 8, 14764.

Wang, B.; Tan, X.-F.; Thurmond, S.; Zhang, Z.-M.; Lin, A.; Hai, R.; Song, J. The structure of Zika virus NS5 reveals a conserved domain conformation. Nat. Commun. 2017, 8, 14763.

Duan, W.; Song, H.; Wang, H.; Chai, Y.; Su, C.; Qi, J.; Shi, Y.; Gao, G.F. The crystal structure of Zika virus NS5 reveals conserved drug targets. EMBO J. 2017, 36, 919–933.

Ashour, J.; Laurent-Rolle, M.; Shi, P.-Y.; García-Sastre, A. NS5 of dengue virus mediates STAT2 binding and degradation. J. Virol. 2009, 83, 5408–5418.

De Maio, F.A.; Risso, G.; Iglesias, N.G.; Shah, P.; De Maio, F.A.; Risso, G.; Iglesias, N.G.; Shah, P.; Pozzi, B.; Gebhard, L.G.; et al. The Dengue Virus NS5 Protein Intrudes in the Cellular Spliceosome and Modulates Splicing. PLoS Pathog. 2016, 12, 1–29.

Calixto JB, Braz J Med Biol Res. 2000 33: 179 [PMID: 10657057].

Kubmarawa D et al. J Med Plants Res. 2008 2: 352.

Idrees S et al. Asian Pac J Trop Biomed. 2013 3: 232 [PMID: 23620845].

Qamar TU et al. Bioinformation 2014 19: 115 [PMID: 24748749].

Jassim SA & Naji MA, J Appl Microbiol. 2003 95: 412 [PMID: 12911688].

Yap T. L., Xu T., Chen Y. L., Malet H., Egloff M.-P., Canard B., Vasudevan S. G., Lescar J. (2007) The crystal structure of the Dengue virus RNA-dependent RNA polymerase at 1.85 Å resolution. J. Virol. 81, 4753–4765.

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


  • There are currently no refbacks.

Copyright (c) 2017 International Journal of Advances in Pharmaceutics